ASN Podcast

Hosts Tod Ibrahim and David White are joined by colleague Zach Kribs to provide an update on the status of Congressional funding legislation and ASN's advocacy priorities. This episode mainly focuses on the House Appropriations Committee.

Hosts Tod Ibrahim and David White discuss the recently released CY2025 End-Stage Renal Disease Prospective Payment System and Quality Incentive Program (ESRD PPS QIP) proposed rule and the CY2025 Medicare Physician Fee Schedule proposed rule.

In this new series, Drs. Alice Sheridan and Martina McGrath speak with guest editor Dr. Michael Emmett to discuss his editorial "Cystic Fibrosis and Hypoelectrolytemia With Metabolic Alkalosis" from nephSAP Volume 23, Number 2.

Hosts Tod Ibrahim and David White discuss the Center for Medicare and Medicaid Innovation's recently announced Increasing Organ Transplant Access (IOTA) Model proposed rule.

Hosts Tod Ibrahim and David White are joined by colleague Zach Kribs, ASN Manager of Congressional Affairs to discuss ASN's recent Capitol Hill advocacy on transplant.

David White is joined by Health Policy Scholar in Residence Dr. Suzanne Watnick and Zach Kribs to discuss the Kidney PATIENT Act of 2023- a bill that would delay the inclusion oral only drugs in the ESRD PPS.

Quality and Regulatory Affairs Associate Lauren Ahearn is joined by Congressional Affairs Manager Zach Kribs to discuss the possible March partial government shutdown as well as congressional action on the Medicare physician reimbursement cut.

Hosts Tod Ibrahim and David White welcome longtime ASN policy strategist and attorney Andrew Shore from JST Strategies, LLC to discuss SCOTUS's upcoming decision in Relentless vs. Department of Commerce and its potential impact on federal rulemaking.

Join hosts Tod Ibrahim and David White to discuss Congress' recent passage of a stop-gap budget bill and the Center for Medicare & Medicaid's prior authorizations final rule.

Congressional Affairs Manager Zach Kribs joins hosts Tod Ibrahim and David White to discuss what to expect this year in both federal regulatory and Congressional health care policy.